Product Information
IMITREX 6 MG/0.5 ML CARTRIDGES is a brand product labeled by GlaxoSmithKline LLC, priced at $437.5217 per ML under NDC 00173047800. Its NADAC has been published 650 times since Nov 28, 2013.
FDA first approved this application on Dec 28, 1992. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the sumatriptan market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
6 mg/.5mL
Manufacturer
GlaxoSmithKline LLCNDC
00173047800
Classification
Brand
Dosage Form
INJECTION
Route
SUBCUTANEOUS
Effective Date
8/19/2026
Active Ingredients
SUMATRIPTAN SUCCINATEApproval Type
New Drug (NDA)
FDA Application
NDA020080FDA Approved
12/28/1992
TE Code
AB
On Market Since
1/27/1997
Pharmacological Classes
Price Statistics
The NADAC for IMITREX 6 MG/0.5 ML CARTRIDGES has been published 650 times since Nov 28, 2013, and over the history we have for it it has risen 128.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $437.5217 per ML |
|---|---|
| All-time high | $442.6790 (Jul 10, 2024) |
| All-time low | $191.4632 (Nov 28, 2013) |
| 52-week high | $437.5630 |
| 52-week low | $435.9192 |
| Median price | $385.8228 |
| Average price | $369.7953 |
| Largest weekly change | +15.0% (Dec 30, 2015) |
| Weeks tracked | 650 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 97% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of IMITREX 6 MG/0.5 ML CARTRIDGES?
The current National Average Drug Acquisition Cost (NADAC) for IMITREX 6 MG/0.5 ML CARTRIDGES, manufactured by GlaxoSmithKline LLC, is $437.5217 per ML (NDC 00173047800), effective Aug 19, 2026.
How has the price of IMITREX 6 MG/0.5 ML CARTRIDGES changed over time?
Over the history we have for it, the NADAC for IMITREX 6 MG/0.5 ML CARTRIDGES has risen 128.5%. It has been tracked across 650 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for IMITREX 6 MG/0.5 ML CARTRIDGES?
Since Nov 28, 2013, the NADAC for IMITREX 6 MG/0.5 ML CARTRIDGES has ranged from a low of $191.4632 (Nov 28, 2013) to a high of $442.6790 (Jul 10, 2024), with a median of $385.8228 per ML.
Are there cheaper alternatives to IMITREX 6 MG/0.5 ML CARTRIDGES?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SUMATRIPTAN 6 MG/0.5 ML VIAL, is $15.2470 per ML — about 97% below IMITREX 6 MG/0.5 ML CARTRIDGES.
Who manufactures IMITREX 6 MG/0.5 ML CARTRIDGES?
IMITREX 6 MG/0.5 ML CARTRIDGES (NDC 00173047800) is labeled by GlaxoSmithKline LLC, and CMS classifies it as a brand product.